Anabolic and anticatabolic agents in critical care

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Current Opinion in Critical Care

• Publication date

  2016-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MCC.0000000000000330PMID 27272101PMCID PMC7859865
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Concepts of stress

  2017cited by this paper
• Glucose Control in Severely Burned Patients Using Metformin: An Interim Safety and Efficacy Analysis of a Phase II Randomized Controlled Trial

  2016cited by this paper
• Long-Term Administration of Oxandrolone Improves Lung Function in Pediatric Burned Patients

  2016cited by this paper
• FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL

  2015cited by this paper
• The Effect of Ketoconazole on Post-Burn Inflammation, Hypermetabolism and Clinical Outcomes

  2012cited by this paper
• Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy.

  2012cited by this paper
• Long-Term Propranolol Use in Severely Burned Pediatric Patients: A Randomized Controlled Study

  2012cited by this paper
• Propranolol decreases cardiac work in a dose-dependent manner in severely burned children.

  2011cited by this paper
• Long-Term Persistance of the Pathophysiologic Response to Severe Burn Injury

  2011cited by this paper
• Insulin effects in muscle and adipose tissue.

  2011cited by this paper
• Glucose Control in Severely Thermally Injured Pediatric Patients: What Glucose Range Should Be the Target?

  2010cited by this paper
• The evolutionary role of nutrition and metabolic support in critical illness.

  2010cited by this paper
• Randomized Controlled Trial to Determine the Efficacy of Long-Term Growth Hormone Treatment in Severely Burned Children

  2009cited by this paper
• Pathophysiologic Response to Severe Burn Injury

  2009influential reference
• The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study

  2009cited by this paper
• Modulation of the hypermetabolic response to trauma: temperature, nutrition, and drugs.

  2009influential reference
• Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn.

  2009influential reference
• The hypermetabolic response to burn injury and interventions to modify this response.

  2009influential reference
• Pathophysiologic Response to Severe Burn Injury

  2008cited by this paper
• Combination of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children*

  2008cited by this paper
• Gender Differences in Pediatric Burn Patients: Does It Make a Difference?

  2008cited by this paper
• Intensive insulin therapy and pentastarch resuscitation in severe sepsis.

  2008cited by this paper
• Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

  2007cited by this paper
• Insulin Sensitivity and Mitochondrial Function Are Improved in Children With Burn Injury During a Randomized Controlled Trial of Fenofibrate

  2007cited by this paper
• Effect of intensive insulin therapy on insulin sensitivity in the critically ill.

  2007cited by this paper
• Beta-blockade in burns.

  2007cited by this paper
• The Effect of Oxandrolone on the Endocrinologic, Inflammatory, and Hypermetabolic Responses During the Acute Phase Postburn

  2007cited by this paper
• Evolution of concepts of stress

  2007cited by this paper
• Glucose metabolism and insulin therapy.

  2006cited by this paper
• Effects of Oxandrolone on Outcome Measures in the Severely Burned: A Multicenter Prospective Randomized Double-Blind Trial

  2006cited by this paper
• Effects of growth hormone on anthropometric measurements and cardiac function in children with thermal injury.

  2005cited by this paper
• Endogenous Anabolic Hormones and Hypermetabolism: Effect of Trauma and Gender Differences

  2005cited by this paper
• Influence of Metformin on Glucose Intolerance and Muscle Catabolism Following Severe Burn Injury

  2005cited by this paper
• Insulin-like growth factor I: the yin and yang of muscle atrophy.

  2004cited by this paper
• Glucose control and mortality in critically ill patients.

  2004cited by this paper
• Effects of long-term oxandrolone administration in severely burned children.

  2004cited by this paper
• Insulin Treatment Improves the Systemic Inflammatory Reaction to Severe Trauma

  2004cited by this paper
• Fasting plasma free fatty acids and risk of type 2 diabetes: the atherosclerosis risk in communities study.

  2004cited by this paper
• Support of the metabolic response to burn injury.

  2004cited by this paper
• Extended hypermetabolic response of the liver in severely burned pediatric patients.

  2004cited by this paper
• Metformin blunts stress-induced hyperglycemia after thermal injury.

  2003cited by this paper
• Growth Hormone Down-Regulation of Interleukin-1&bgr; and Interleukin-6 Induced Acute Phase Protein Gene Expression is Associated with Increased Gene Expression of Suppressor of Cytokine Signal-3

  2003cited by this paper
• Effect of exogenous growth hormone and exercise on lean mass and muscle function in children with burns.

  2003cited by this paper
• β-blockade and growth hormone after burn

  2002cited by this paper
• Beta-blockade and growth hormone after burn.

  2002cited by this paper
• Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned children

  2002cited by this paper
• The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn.

  2002cited by this paper
• Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans.

  2002cited by this paper
• Anabolic Effects of Oxandrolone After Severe Burn

  2001cited by this paper
• Efficacy of a high-carbohydrate diet in catabolic illness

  2001cited by this paper
• The effect of short-term growth hormone treatment on growth and energy expenditure in burned children.

  2001cited by this paper
• Testosterone administration in severe burns ameliorates muscle catabolism

  2001cited by this paper
• Fatty infiltration of the liver in severely burned pediatric patients: autopsy findings and clinical implications.

  2001cited by this paper
• A potent PPARalpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle.

  2001cited by this paper
• Reversal of catabolism by beta-blockade after severe burns.

  2001influential reference
• The rate of restoration of body weight after burn injury, using the anabolic agent oxandrolone, is not age dependent.

  2001cited by this paper
• Increased mortality associated with growth hormone treatment in critically ill adults.

  2000cited by this paper
• Recombinant human growth hormone treatment in pediatric burn patients and its role during the hepatic acute phase response

  2000cited by this paper
• The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury.

  2000cited by this paper
• Persistence of muscle catabolism after severe burn.

  2000cited by this paper
• Determinants of Skeletal Muscle Catabolism After Severe Burn

  2000cited by this paper
• Increased mortality associated with growth hormone treatment in critically ill adults.

  1999cited by this paper
• Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity.

  1999cited by this paper
• Insulin receptor down-regulation and impaired antilipolytic action of insulin in diabetic patients after pancreas/kidney transplantation.

  1994cited by this paper
• Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output.

  1992cited by this paper
• Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes.

  1983cited by this paper
• Ketoconazole blocks adrenal steroid synthesis.

  1982cited by this paper
• The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

  1963cited by this paper

• Gross and Histopathological Changes in Pancreas in Cases of Death Due to Thermal Burn Injury: A Cross-sectional Autopsy-based Study

  2026cites this paper
• Post-intensive care syndrome follow-up system after hospital discharge: a narrative review

  2024cites this paper
• Metformin is associated with reduced risk of mortality and morbidity in burn patients compared to insulin.

  2024cites this paper
• Novel Strategies to Promote Intensive Care Unit Recovery via Personalized Exercise, Nutrition, and Anabolic Interventions.

  2024cites this paper
• (Mal)nutrition in critical illness and beyond: a narrative review

  2023cites this paper
• The Good, the Bad, and the Serum Creatinine: Exploring the Effect of Muscle Mass and Nutrition

  2023cites this paper
• Pharmacotherapies for muscle wasting in older ICU patients: A narrative review of the

  2023cites this paper
• Personalized nutrition therapy in critical care: 10 expert recommendations

  2023cites this paper
• Endocrine disorders in burn disease. Literature review

  2023cites this paper
• Metabolic and Nutritional Support.

  2023cites this paper
• Postacute Sequelae of COVID-19 Critical Illness

  2022cites this paper
• Exercise Limitation after Critical Versus Mild COVID-19 Infection: A Metabolic Perspective

  2022cites this paper
• Cardiopulmonary Exercise Testing in Critically Ill Coronavirus Disease 2019 Survivors: Evidence of a Sustained Exercise Intolerance and Hypermetabolism

  2021cites this paper
• A Screening Tool to Detect Chronic Critically Ill Cardiac Surgery Patients at Risk for Low Levels of Testosterone and Somatomedin C: A Prospective Observational Pilot Study

  2021cites this paper
• Glucose Metabolism in Burns—What Happens?

  2021cites this paper
• Androgens’ Role in Severity and Mortality Rates of COVID-19

  2021cites this paper
• Prevalence of nutritional risk and malnutrition during and after hospitalization for COVID-19 infection: Preliminary results of a single-centre experience

  2021cites this paper
• Role of anabolic testosterone agents and structured exercise to promote recovery in ICU survivors

  2020cites this paper
• β-Hydroxy-β-methylbutyrate, Arginine, and Glutamine Complex on Muscle Volume Loss in Critically Ill Patients: A Randomized Control Trial.

  2020cites this paper
• Review: Insulin resistance and mitochondrial dysfunction following severe burn injury.

  2020cites this paper
• Burn injury insulin resistance and central nervous system complications: A review

  2020cites this paper
• The association between the route of nutrition and serum levels of adipokines in critical illness: a pilot study

  2020cites this paper
• Why does COVID‐19 kill more elderly men than women? Is there a role for testosterone?

  2020cites this paper
• The Safety and Effect of Early Mobilization in the Intensive Care Unit According to Cancellation Criteria

  2020cites this paper
• Serum Creatinine, Muscle Mass, and Nutritional Status in Intensive Care

  2020cites this paper
• Oxandrolone Use Causes Dyslipidemia in Resistance-Training Practitioners

  2020cites this paper
• Post‐intensive care syndrome: its pathophysiology, prevention, and future directions

  2019cites this paper
• Anabolic and anticatabolic agents used in burn care: What is known and what is yet to be learned.

  2019cites this paper
• Survey of critical care practice in Australian and New Zealand burn referral centres.

  2019cites this paper
• Nutrition therapy and critical illness: practical guidance for the ICU, post-ICU, and long-term convalescence phases

  2019cites this paper
• Nutrition Therapy in Sepsis.

  2018cites this paper
• Pérdida de masa muscular en el paciente críticamente enfermo: ¿Caquexia, sarcopenia y/o atrofia? Impacto en la respuesta terapéutica y la supervivencia

  2018cites this paper
• Update on metabolism and nutrition therapy in critically ill burned patients

  2018influential citation
• Sport en réanimation. Intérêt des traitements adjuvants

  2018cites this paper
• [Probiotics: innocuousness, prevention and risks].

  2017cites this paper
• Burns in Children

  2017cites this paper
• Muscle mass and physical recovery in ICU: innovations for targeting of nutrition and exercise

  2017cites this paper
• The biochemical alterations underlying post-burn hypermetabolism.

  2017cites this paper
• Tailoring nutrition therapy to illness and recovery

  2017cites this paper
• Update on metabolism and nutrition therapy in critically ill burn patients.

  2017cites this paper
• Prognostic value of severity by various visceral proteins in critically ill patients with SIRS during 7 days of stay.

  2016cites this paper
• What factors influence protein synthesis and degradation in critical illness?

  2016cites this paper